Navigation Links
Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
Date:11/28/2007

ovative joint restoration products. The company's first product, the OrthoGlide Medial Knee Implant, is intended for the treatment of patients with moderate osteoarthritis of the medial compartment. It is securely implanted without bone cutting or rigid fixation, is expected to provide a more rapid recovery than TKR, a shorter hospital stay and no rehabilitation. The company received 510(k) clearance to market in February 2006 and 350 implants have been completed. For additional information contact ABS at 952.912.5400 or visit the website at http://www.advbiosurf.com.


'/>"/>
SOURCE Advanced Bio-Surfaces, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... ,,,,, SILVER SPRING, Md. , March 18 The U.S. Food and Drug Administration today approved Carbaglu (carglumic acid) Tablets to treat a condition that results in too much ammonia in ... , ... ... (Logo: ...
(Date:3/18/2010)... ChemImage, a world leader in chemical imaging ... ingredient-specific particle sizing (ISPST) study on a combination Metered ... ( www.rddonline.com ).  This conference will take place from ... Florida and will feature thought leaders discussing current ...
(Date:3/18/2010)... , March 18 Solos Endoscopy, Inc. ... has secured the U.S. Trademark for the MammoView® name. ... state-of-the-art endoscopic technology for detecting early stage breast cancer. ... and optical technology to give physicians sharp, clear images ...
Breaking Medicine Technology:FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 2ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 3Solos Endoscopy, Inc. Granted U.S. Trademark for MammoView(R) 2Solos Endoscopy, Inc. Granted U.S. Trademark for MammoView(R) 3Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 1Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 2Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 3Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 4Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 5Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 6Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 7Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 8Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 9Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 10Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 11Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 12Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 13Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 14Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 15Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 16Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 17Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 18Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 19Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 20Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 21Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 22Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 23Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 24Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 25Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 26Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 27Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 28Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 29Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 30Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 31Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 32Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 33Reportlinker Adds Contract Research Outsourcing 28CRO 29 A Global Update of Market Trends 26amp 3B Opportunities 6650 34Serious Pregnancy Complication Detected With MRI 62389 1Serious Pregnancy Complication Detected With MRI 62389 2CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 62387 1CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 62387 2CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer 62387 3
... in Clinical Trials, SEATTLE, Sept. 9 ... in a Phase 1/Phase 2 study of OMS302, ... surgery. At least 60 patients undergoing age-related,cataract extraction ... the,study., "With the initiation of this study, ...
... FluoroPharma, Inc. announced today that,Dr. David Elmaleh, ... on two preclinical studies demonstrating the potential ... agents for detection,of Alzheimer,s disease (AD) and ... in Nice, France on September 10-13, 2008., ...
Other Medicine Technology:Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 3
(Date:3/21/2010)... March 21 Statement from Charmaine Yoest , President & CEO of Americans United for Life Action: , ... ... ... ... "This deal to pass the largest expansion of abortion since Roe v. Wade is ...
(Date:3/21/2010)... first time in humans, scientists used RNA to ... March 21 (HealthDay News) -- For the first ... gene-manipulation therapy to enter tumor cells and block ... cancer, researchers report. , "They,re basically putting ... don,t want this protein expressed for now," explained ...
(Date:3/18/2010)... , ... , ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on ...
(Date:3/18/2010)... ,,, State Leaders Urged to Support Higher Tobacco Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... WASHINGTON , March 18 ...
(Date:3/18/2010)... , ... ... WASHINGTON , March 18 The following is a statement by Cheryl G. Healton , Dr PH, President and CEO, Legacy(SM): , ... , , ...
Breaking Medicine News(10 mins):Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 2Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 3Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5
... ... nutrition curriculum, BENSENVILLE, Ill., Oct. 7 ... a comprehensive diet and,nutrition curriculum to all of its Head Start ... impact on lowering childhood,obesity and diabetes in minority children. Lifelink also ...
... Everything a Man Wanted to Know But Was Afraid ... are 4.3 million babies born,in the U.S. each year ... until,now. BEING DAD is a revealing, entertaining and inspirational ... fathers who,have recently gone through the pregnancy and delivery ...
... unlike vegetative state , , TUESDAY, Oct. 7 (HealthDay ... "minimally conscious state" may still feel pain and ... , A minimally conscious state (MCS) is different ... wakefulness without awareness of self or surroundings. MCS ...
... Oct. 7 The Catholic Health,Association of the ... Initiatives (CHI), Denver; Covenant Health Systems, Lexington, MA;,and ... ministry-wide effort to,raise awareness about global climate change., ... the National Religious,Partnership for the Environment (NRPE) and ...
... Articles on Breast Cancer and Shopping,Offers Benefitting Women ... BOOMj, Inc. (OTC,Bulletin Board: BOMJ) http://www.BOOMj.com, ... adults over the age of 35 today announced,its ... cancer., (Logo: http://www.newscom.com/cgi-bin/prnh/20070131/BOOMJLOGO ), ...
... 7 Stallergenes S.A.,today announced that they have ... promotion and distribution in Europe of adrenaline,autoinjector, ADREFLEX(R), ... PLC., ADREFLEX(R) consists of a syringe pre-filled ... paediatric use (0.3 and 0.15 mg), in an,autoinjector ...
Other Medicine News:Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 3Health News:BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guy's Point of View 2Health News:Patients in Minimally Conscious State May Still Feel Pain 2Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 3Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: